跳至主要内容
临床试验/CTRI/2010/091/001496
CTRI/2010/091/001496已完成3 期

Evaluation of efficacy and safety of two bronchodilators for the treatment of bronchial asthma: a randomized, open label, active controlled, multicentric study.

Sun Pharmaceutical Industries Ltd., Acme Plaza, Andheri Kurla Road, Andheri East, Mumbai ? 400059. Maharashtra. India.0 个研究点目标入组 200 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
200

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Patients aged between 18 and 65 years.
  • 2. Patients diagnosed with bronchial asthma.
  • 3. Patients willing to give informed consent.

排除标准

  • 1. Pregnant, lactating women or women of childbearing age who are not using an acceptable method of birth control.
  • 2. Patients with suspected hypersensitivity and/or contraindication to the study medication or rescue medications.
  • 3. Patients suffering from lung disease other than asthma.
  • 4. Patients with history of non-compliance to medical regimens or those patients unwilling to comply with the study protocol.
  • 5. Patients with any severe illness like liver insufficiency, active hepatitis, known infection with HIV etc.
  • 6. Patients who have been hospitalized for asthma within three month before the study.
  • 7. Patients having any musculoskeletal, cardiovascular, or neurological condition or any other condition likely to adversely affect exercise performance or measurement of lung function.
  • 8. Patients having disease like hyperthyroidism, heart disease and diabetes mellitus.

研究者

发起方
Sun Pharmaceutical Industries Ltd., Acme Plaza, Andheri Kurla Road, Andheri East, Mumbai ? 400059. Maharashtra. India.

相似试验

A clinical trial to study the effects of two... | 临床试验